Evidence map›Paper›PMID 39540155›Full record

ArticleFrontiers in oncology2024

Case report: A second case of cerebral cavernous malformation after high-dose chemotherapy for medulloblastoma.

Maria Grazia Pionelli, Federica Mazio, Maria Elena Errico, Carmela Russo, Adriana Cristofano, Eugenio Maria Covelli, Vittoria Donofrio, Maria Capasso, Michele Antonio Capozza, Fabiola De Gregorio and 3 more

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Maria Grazia Pionelli *Pediatric Oncology Unit, Department of Pediatric Onco-Hematology, Santobono-Pausilipon Children's Hospital, AORN, Naples, Italy.
Federica Mazio *Neuroradiology Unit, Department of Neuroscience, Santobono-Pausilipon Children's Hospital, AORN, Naples, Italy.
Maria Elena ErricoPathology Unit, Department of Pathology, Santobono-Pausilipon Children's Hospital, AORN, Naples, Italy.
Carmela RussoNeuroradiology Unit, Department of Neuroscience, Santobono-Pausilipon Children's Hospital, AORN, Naples, Italy.
Adriana CristofanoNeuroradiology Unit, Department of Neuroscience, Santobono-Pausilipon Children's Hospital, AORN, Naples, Italy.
Eugenio Maria CovelliNeuroradiology Unit, Department of Neuroscience, Santobono-Pausilipon Children's Hospital, AORN, Naples, Italy.
Vittoria DonofrioPathology Unit, Department of Pathology, Santobono-Pausilipon Children's Hospital, AORN, Naples, Italy.
Maria CapassoPediatric Oncology Unit, Department of Pediatric Onco-Hematology, Santobono-Pausilipon Children's Hospital, AORN, Naples, Italy.
Michele Antonio CapozzaPediatric Oncology Unit, Department of Pediatric Onco-Hematology, Santobono-Pausilipon Children's Hospital, AORN, Naples, Italy.
Fabiola De GregorioPediatric Oncology Unit, Department of Pediatric Onco-Hematology, Santobono-Pausilipon Children's Hospital, AORN, Naples, Italy.
Serena RuotoloPediatric Oncology Unit, Department of Pediatric Onco-Hematology, Santobono-Pausilipon Children's Hospital, AORN, Naples, Italy.
Massimo Eraldo AbatePediatric Oncology Unit, Department of Pediatric Onco-Hematology, Santobono-Pausilipon Children's Hospital, AORN, Naples, Italy.
Giuseppe CinalliPediatric Neurosurgery Unit, Department of Neurosciences, Santobono-Pausilipon Children's Hospital, AORN, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of cerebral cavernous malformations (CCMs) is a well-recognized sequela of irradiation to the brain in pediatric tumors, particularly in medulloblastoma, glioma, and acute lymphoblastic leukaemia. So far, only one case of cerebral cavernoma after chemotherapy with autologous hematopoietic stem cell transplantation (HSCT) has been described. We describe a case of a patient with medulloblastoma aged 18 months at the time of oncological diagnosis who was treated with high-dose chemotherapy followed by HSCT and who developed CCM two years later. The patient was not treated for vascular malformation since he remained asymptomatic until now and is regularly followed with neuro-radiological check-ups. This represents the second case of acquired cavernoma developed in a patient who has not received radiation therapy.

Indexed as

cavernomacavernous hemangiomacerebral cavernous malformationhigh-dose chemotherapymedulloblastoma

Identifiers

PMID39540155
PMCPMC11557518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.